OM
Outset Medical, Inc. (NASDAQ)
Healthcare — Medical Devices
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Price History
Fundamentals
| Market Cap | $94.54M |
| P/E Ratio (TTM) | - |
| Forward P/E | -2.34 |
| EPS (TTM) | $-2.74 |
| Dividend Yield | - |
| Profit Margin | -63.65% |
| Revenue Growth | -6.30% |
| ROE | -53.17% |
| Debt/Equity | 90.98 |
| Recommendation | Buy 1.7 |
| Analyst Target | $7.67 |
| Analysts | 3 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 56.5 |
| Beta | 1.94 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $21.36 |
| 52-Week Low | $3.00 |
| 50-Day Avg | $4.42 |
| 200-Day Avg | $6.24 |
| Avg Volume | 215.2K |
| Volume | 313.3K |
Performance Analysis
NEUTRALOM presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:24 UTC
Back to Screener Export Report